---
document_datetime: 2025-12-02 05:27:30
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/clopidogrel-acetylsalicylic-acid-teva.html
document_name: clopidogrel-acetylsalicylic-acid-teva.html
version: success
processing_time: 0.1133175
conversion_datetime: 2025-12-27 20:17:43.405823
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Clopidogrel/Acetylsalicylic acid Teva

[RSS](/en/individual-human-medicine.xml/65940)

##### Withdrawn

This medicine's authorisation has been withdrawn

clopidogrel / acetylsalicylic acid Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Clopidogrel/Acetylsalicylic acid Teva](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 3 June 2016, the European Commission withdrew the marketing authorisation for Clopidogrel/Acetylsalicylic acid Teva (clopidogrel / acetylsalicylic acid) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Teva Pharma B.V., which notified the European Commission of its decision not to market the product in the EU for commercial reasons.

Clopidogrel/Acetylsalicylic acid Teva was granted marketing authorisation in the EU on 1 September 2014 for the prevention of atherothrombotic events. Clopidogrel/Acetylsalicylic acid Teva is a medicine that contains two active substances, clopidogrel and acetylsalicylic. There are other medicinal products marketed in the EU that contain this combination of substances as well as products containing clopidogrel or acetylsalicylic alone.

The European Public Assessment Report (EPAR) for Clopidogrel/Acetylsalicylic acid Teva is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Clopidogrel / Acetylsalicylic acid Teva : EPAR - Summary for the public

Reference Number: EMA/558791/2014

English (EN) (551.84 KB - PDF)

**First published:** 26/09/2014

**Last updated:** 28/04/2017

[View](/en/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-49)

български (BG) (640.29 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/bg/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_bg.pdf)

español (ES) (551.49 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/es/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_es.pdf)

čeština (CS) (619.76 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/cs/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_cs.pdf)

dansk (DA) (553.34 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/da/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_da.pdf)

Deutsch (DE) (552.85 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/de/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_de.pdf)

ελληνικά (EL) (644.13 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/el/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_el.pdf)

français (FR) (552.72 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/fr/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_fr.pdf)

hrvatski (HR) (572.63 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/hr/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_hr.pdf)

italiano (IT) (572.75 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/it/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_it.pdf)

latviešu valoda (LV) (616.07 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/lv/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (579.55 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/lt/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_lt.pdf)

magyar (HU) (611.27 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/hu/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_hu.pdf)

Malti (MT) (621.63 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/mt/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_mt.pdf)

Nederlands (NL) (549.73 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/nl/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_nl.pdf)

polski (PL) (618.45 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/pl/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_pl.pdf)

português (PT) (551.97 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/pt/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_pt.pdf)

română (RO) (577.7 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/ro/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_ro.pdf)

slovenčina (SK) (616.92 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/sk/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_sk.pdf)

slovenščina (SL) (608.26 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/sl/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_sl.pdf)

Suomi (FI) (548.85 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/fi/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_fi.pdf)

svenska (SV) (550.28 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/sv/documents/overview/clopidogrel-acetylsalicylic-acid-teva-epar-summary-public_sv.pdf)

Clopidogrel / Acetylsalicylic acid Teva : EPAR - Risk-management-plan summary

Reference Number: EMA/411850/2014

English (EN) (554.72 KB - PDF)

**First published:** 26/09/2014

**Last updated:** 28/04/2017

[View](/en/documents/rmp-summary/clopidogrel-acetylsalicylic-acid-teva-epar-risk-management-plan-summary_en.pdf)

## Product information

Clopidogrel / Acetylsalicylic acid Teva : EPAR - Product Information

English (EN) (1.15 MB - PDF)

**First published:** 26/09/2014

**Last updated:** 28/04/2017

[View](/en/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-244)

български (BG) (2.74 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/bg/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_bg.pdf)

español (ES) (1.22 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/es/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_es.pdf)

čeština (CS) (2.14 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/cs/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_cs.pdf)

dansk (DA) (1.17 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/da/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_da.pdf)

Deutsch (DE) (1.21 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/de/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_de.pdf)

eesti keel (ET) (1.15 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/et/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_et.pdf)

ελληνικά (EL) (2.84 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/el/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_el.pdf)

français (FR) (1.23 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/fr/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_fr.pdf)

hrvatski (HR) (1.26 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/hr/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_hr.pdf)

íslenska (IS) (1.2 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/is/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_is.pdf)

italiano (IT) (1.41 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/it/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_it.pdf)

latviešu valoda (LV) (2.16 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/lv/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.27 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/lt/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_lt.pdf)

magyar (HU) (2.22 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/hu/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_hu.pdf)

Malti (MT) (2.24 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/mt/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_mt.pdf)

Nederlands (NL) (1.19 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/nl/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_nl.pdf)

norsk (NO) (1.16 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/no/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_no.pdf)

polski (PL) (2.29 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/pl/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_pl.pdf)

português (PT) (1.2 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/pt/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_pt.pdf)

română (RO) (1.26 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/ro/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_ro.pdf)

slovenčina (SK) (2.24 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/sk/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_sk.pdf)

slovenščina (SL) (2.09 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/sl/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_sl.pdf)

Suomi (FI) (1.31 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/fi/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_fi.pdf)

svenska (SV) (1.16 MB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/sv/documents/product-information/clopidogrel-acetylsalicylic-acid-teva-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IA/0002 03/06/2016

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Clopidogrel / Acetylsalicylic acid Teva : EPAR - All Authorised presentations

English (EN) (465.95 KB - PDF)

**First published:** 26/09/2014

**Last updated:** 28/04/2017

[View](/en/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-386)

български (BG) (559.88 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/bg/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_bg.pdf)

español (ES) (466.06 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/es/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_es.pdf)

čeština (CS) (525.42 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/cs/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (466.53 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/da/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (467.23 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/de/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (470.64 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/et/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (538.45 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/el/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_el.pdf)

français (FR) (466.03 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/fr/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (514.42 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/hr/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (465.5 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/is/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_is.pdf)

italiano (IT) (467.22 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/it/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (528.72 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/lv/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (517.37 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/lt/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (522.9 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/hu/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (559.02 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/mt/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (465.99 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/nl/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (465.81 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/no/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_no.pdf)

polski (PL) (498.85 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/pl/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_pl.pdf)

português (PT) (466.07 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/pt/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_pt.pdf)

română (RO) (513.43 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/ro/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (542.59 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/sk/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (525.83 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/sl/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (467.09 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/fi/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (466.42 KB - PDF)

**First published:**

26/09/2014

**Last updated:**

28/04/2017

[View](/sv/documents/all-authorised-presentations/clopidogrel-acetylsalicylic-acid-teva-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Clopidogrel/Acetylsalicylic acid Teva Active substance

- clopidogrel
- acetylsalicylic acid

International non-proprietary name (INN) or common name

- clopidogrel
- acetylsalicylic acid

Therapeutic area (MeSH)

- Acute Coronary Syndrome
- Myocardial Infarction

Anatomical therapeutic chemical (ATC) code B01AC30

### Pharmacotherapeutic group

combinations

### Therapeutic indication

Clopidogrel/Acetylsalicylic acid Teva is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (ASA). Clopidogrel/Acetylsalicylic acid Teva is a fixed?dose combination medicinal product for continuation of therapy in:

- Non?ST segment elevation acute coronary syndrome (unstable angina or non?Q?wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention

ST segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

## Authorisation details

EMA product number EMEA/H/C/002272 Marketing authorisation holder

Teva Pharma B.V.

Swensweg 5

Opinion adopted 26/06/2014 Marketing authorisation issued 01/09/2014 Withdrawal of marketing authorisation 03/06/2016 Revision 1

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Clopidogrel/Acetylsalicylic acid Teva : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (523.44 KB - PDF)

**First published:** 11/04/2016

**Last updated:** 28/04/2017

[View](/en/documents/procedural-steps-after/clopidogrelacetylsalicylic-acid-teva-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Clopidogrel / Acetylsalicylic acid Teva : EPAR - Public assessment report

Adopted

Reference Number: EMA/CHMP/333195/2014

English (EN) (1.5 MB - PDF)

**First published:** 26/09/2014

**Last updated:** 28/04/2017

[View](/en/documents/assessment-report/clopidogrel-acetylsalicylic-acid-teva-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Clopidogrel / Acetylsalicylic acid Teva

Adopted

Reference Number: EMA/CHMP/369651/2014

English (EN) (563.03 KB - PDF)

**First published:** 27/06/2014

**Last updated:** 28/04/2017

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-clopidogrel-acetylsalicylic-acid-teva_en.pdf)

#### News on Clopidogrel/Acetylsalicylic acid Teva

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 June 2014](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-23-26-june-2014) 27/06/2014

**This page was last updated on** 28/04/2017

## Share this page

[Back to top](#main-content)